About Vidium

A world where pets' lives are not limited by disease. That is what drives us.
Genome

A new way.

By informing veterinarians and pet parents about which mutations are causing their pet’s cancer to grow and spread, we intend to open up the use of precision medicine to combat canine cancer in new and more effective ways.

Vidium is dedicated to unravelling the genetic components of common and complex diseases, including cancer. As a result, the practice of medicine targeting these conditions can be more rational, more precise and more personal. Our focus is on shifting paradigms in cancer treatment to enable cures for cancer and other serious diseases in pets through programs at the intersection of personalized medicine and comparative genomics.

Dogs Paw
Genome

Our mission.

Advancing understanding of disease and treatment to give the pets we love the fullest lives possible.

Genome

What we believe.

We believe that when pets win, everyone wins.
Do good science that does good.
All of us are smarter than any of us.
Be a good human, sometimes you can be a hero.
It is our individual weirdness that makes us a better team.
We challenge the impossible.
Our science is unimpeachable.
Man Hughing A Golden Dog
Two Dogs Playing
Two Dogs Smiling On The Desert

Leadership

David Dog David Haworth

David Haworth, DVM, PhD

Co-Founder & President

William Dog William Hendricks

William Hendricks, PhD

Founder and Chief Scientific Officer

Katie Dog Katie Banovich

Katie Banovich

Co-Founder & Director of Operations

Zhu Dog 210512 Ch Vidium Leadership Bio Light Zhu

Zhanyang Zhu, PhD

Head of Bioinformatics and Product Development

210512 Ch Vidium Leadership Bio Dogs Guannan V1 1guannan Wang Photo Copy

Guannan Wang, PhD

Head of Clinical Curation

210512 Ch Vidium Leadership Bio Dogs Andy Chon V1 210512 Ch Vidium Leadership Bio Light Chon

Esther Chon, DVM, DACVIM (Oncology)

Head of Veterinary Affairs

Luna 420x420 Whitley Bw 420x420

Derick Whitley, DVM, Diplomate ACVP

Vice President of Strategy, Innovation and Diagnostics

Genome

Advisory Board

210507 Ch Vidium Advisory Board Bio Light Bergman 210507 Ch Vidium Advisory Board Bio Dark Bergman

Phil Bergman

DVM, PhD, DACVIM

210507 Ch Vidium Advisory Board Bio Light Clifford 210507 Ch Vidium Advisory Board Bio Dark Clifford

Craig A. Clifford

DVM, MS, DACVIM (Oncology)

210507 Ch Vidium Advisory Board Bio Light Lorch 210507 Ch Vidium Advisory Board Bio Dark Lorch

Gwendolen Lorch

DVM, MS, PhD

210507 Ch Vidium Advisory Board Bio Light Huentleman 210507 Ch Vidium Advisory Board Bio Dark Huentleman

Matt Huentelman

PhD

210507 Ch Vidium Advisory Board Bio Light Schork 210507 Ch Vidium Advisory Board Bio Dark Schork

Nicholas J. Schork

PhD

210507 Ch Vidium Advisory Board Bio Light Papadopoulos 210507 Ch Vidium Advisory Board Bio Dark Papadopoulos

Nickolas Papadopoulos

PhD

The future of pet cancer care is here.

By analyzing the DNA of your pet’s tumor cells, Vidium’s SearchLight DNA™ can inform your veterinary team about what mutations might exist within that tumor, what is driving the tumor’s growth, and what treatments might be effective to help make your dog well again.

Place Order